Global Health News and Updates

Name: Latest research reports of Global Health Ltd. authored by Prabhudas Lilladhar and published by - Trendlyne research reports.
Item: Global Health Ltd.
Rating: 5
Author: Prabhudas Lilladhar

Keep track of all breaking news on Global Health from all sources in a single place.

Global Health Ltd.

25 Aug 2026

1447.20

-0.85%

Global Health (MEDANTA IN) Company Update Strong growth outlook BUY

Buy: Global Health Ltd.

Target

Prabhudas Lilladhar

Global Health (MEDANTA IN) Company Update Strong growth outlook BUY

Global Health Ltd. has an average target of 1525.00 from 4 brokers.

Global Health Ltd.

18 Aug 2026

1447.20

-0.85%

Lord's Mark Industries Outlines Strategic Expansion Across Global Healthcare, Advanced Diagnostics & Oncology; Targets 1,550 Crore Revenue in FY2027

Business Standard

Institutions build trust, these pieces show, not by doing more, but by making their actions add up

Prabhudas Lilladhar increased Buy price target of Global Health Ltd. to 1750.0 on 25 Aug, 2026.

Global Health Ltd.

03 Aug 2026

1447.20

-0.85%

Broker's Call: Global Health (Hold)

Business Line

Axis Securities

Global Health Ltd. has an average target of 1525.00 from 4 brokers.

Global Health Ltd.

01 Aug 2026

1447.20

-0.85%

Volume-led outperformance continues

Buy: Global Health Ltd.

Target

Motilal Oswal

Global Health (Medanta) delivered a better-than-expected 1QFY27 financial performance, with 12%/13% beat on revenue/EBITDA. 1Q earnings came in slightly below our expectations due to higher depreciation, lower other income and a higher tax rate.

Global Health has gained 31.18% in the last 6 Months

Global Health Ltd.

31 Jul 2026

1447.20

-0.85%

Global Health Results Earnings Call for Q1FY27

Conference Call with Global Health Management and Analysts on Q1FY27 Performance and Outlook. Listen to the full earnings transcript.

audio

Global Health Ltd.

30 Jul 2026

1447.20

-0.85%

to see Rapid results content

Global Health Ltd.

30 Jun 2026

1447.20

-0.85%

Motilal Oswal sector of the week: Healthcare; Max, Global Health top picks

Business Standard

Indian healthcare sector remains well positioned for sustained long-term growth, supported by structural demand, expanding hospital infra, higher healthcare spends, and favourable demographic trends.

Prabhudas Lilladhar increased Buy price target of Global Health Ltd. to 1750.0 on 25 Aug, 2026.

Global Health Ltd.

19 May 2026

1447.20

-0.85%

Above par show, ramp-up of new units to drive earnings; maintain BUY

Buy: Global Health Ltd.

Target

Anand Rathi

Beating our estimate by 9/12/33%, Global Health (Medanta) reported 25/9/42% y/y surge in Revenue/EBITDA/PAT in Q4FY26 with 5% y/y increase in ARPOB to Rs66,687.

Prabhudas Lilladhar increased Buy price target of Global Health Ltd. to 1750.0 on 25 Aug, 2026.

Global Health Ltd.

18 May 2026

1447.20

-0.85%

Global Health (MEDANTA IN) Q4FY26 Result Update Noida unit ramp-up on track BUY

Buy: Global Health Ltd.

Target

Prabhudas Lilladhar

Global Health's (MEDANTA) Q4FY26 EBITDA reported a 6% beat to our estimates with a growth of 13% YoY; largely aided by higher growth across Lucknow and Patna units. Further ramp up in Noida unit on track with losses reducing QoQ. MEDANTA's reported EBITDA growth of 7% CAGR over FY24-26, due to issues at Lucknow unit and start-up losses related to Noida unit in FY26. It has a total bed capacity of ~3,663 and intends to add ~3,190 beds over the next 3-4 years. With Lucknow unit issues largely resolved and ramp-up in Noida to be visible from Q2FY27E, EBITDA is expected to clock ~24% CAGR over FY26-28E. Our FY27 and FY28E EBITDA stands increased by 6%. Maintain...